SG Americas Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712K | Buy |
84,092
+38,849
| +86% | +$329K | ﹤0.01% | 1273 |
|
|
2025
Q1 | $364K | Sell |
45,243
-17,321
| -28% | -$139K | ﹤0.01% | 1828 |
|
|
2024
Q4 | $562K | Sell |
62,564
-485,163
| -89% | -$4.36M | ﹤0.01% | 1053 |
|
|
2024
Q3 | $4.02M | Buy |
547,727
+535,301
| +4,308% | +$3.92M | 0.01% | 430 |
|
|
2024
Q2 | $71K | Sell |
12,426
-1,764
| -12% | -$10.1K | ﹤0.01% | 2279 |
|
|
2024
Q1 | $71K | Sell |
14,190
-21,017
| -60% | -$105K | ﹤0.01% | 2343 |
|
|
2023
Q4 | $317K | Buy |
35,207
+14,025
| +66% | +$126K | ﹤0.01% | 1613 |
|
|
2023
Q3 | $165K | Buy |
+21,182
| New | +$165K | ﹤0.01% | 2202 |
|
|
2022
Q3 | – | Sell |
-22,126
| Closed | -$222K | – | 2787 |
|
|
2022
Q2 | $222K | Sell |
22,126
-779,071
| -97% | -$7.82M | ﹤0.01% | 2361 |
|
|
2022
Q1 | $9.92M | Buy |
801,197
+144,992
| +22% | +$1.8M | 0.07% | 181 |
|
|
2021
Q4 | $15M | Buy |
656,205
+245,417
| +60% | +$5.61M | 0.08% | 151 |
|
|
2021
Q3 | $9.09M | Buy |
410,788
+243,678
| +146% | +$5.39M | 0.04% | 253 |
|
|
2021
Q2 | $2.17M | Buy |
167,110
+94,378
| +130% | +$1.22M | 0.01% | 979 |
|
|
2021
Q1 | $944K | Buy |
+72,732
| New | +$944K | ﹤0.01% | 1434 |
|
|
2020
Q1 | – | Sell |
-5,105
| Closed | -$103K | – | 2842 |
|
|
2019
Q4 | $103K | Sell |
5,105
-41,009
| -89% | -$827K | ﹤0.01% | 2534 |
|
|
2019
Q3 | $246K | Buy |
+46,114
| New | +$246K | ﹤0.01% | 1933 |
|
|
2017
Q1 | – | Sell |
-373,209
| Closed | -$784K | – | 2786 |
|
|
2016
Q4 | $784K | Hold |
373,209
| – | – | 0.01% | 1313 |
|
|
2016
Q3 | $1.12M | Buy |
+373,209
| New | +$1.12M | 0.01% | 962 |
|